Aspects of antihyperglycemic oral bitherapy in 76 cases of non insulindependent diabetes in Dakar;Aspects de la bithérapie antihyperglycémiante orale chez 76 patients diabétiques non insulinodépendants à Dakar

Cahiers Sante

Volumn 12, Issue 3, 2002, Pages 319-322

  Sidibe E H ^a   Badiane, M K ^a   Gueye, A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLIBENCLAMIDE; GLICLAZIDE; GLUCOSE; METFORMIN; SULFONYLUREA;

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; BODY WEIGHT DISORDER; CHOLESTEROL BLOOD LEVEL; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; LIVER METABOLISM; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; POSTPRANDIAL STATE; SOCIOECONOMICS; TREATMENT OUTCOME;

ADULT; AGED; BLOOD GLUCOSE; BODY WEIGHT; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FEMALE; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; OBESITY; SENEGAL;

EID: 0036663746     PISSN: 11575999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Groop L, Widen F, Franssila Kallunki A, et al. Different effects of insulin and oral antidiabetic agent on glucose and energy metabolism in type 2 (non insulin-dependent) diabetes mellitus. Diabetologia 1989; 32: 599-605.
2. Marena S, Tagliaferro V, Montegrosso G, Pagano A, Scaglione L, Pagano G. Metabolic effects of metformin addition to chimic glibenclamide: Treatment in type 2 diabetes. Diabete Metab (Paris), 1994; 20: 15-9.
3. Elkeles RS. The effects of oral hypoglycemic drugs on serum lipids and lipoprotein in non insulin-dependent diabetes (NIDDM). Diabete Metab 1991; 17: 197-200.
4. Nair C, Askar A, Wilson JD, Dhall DP. Studies on fibrin network structure in human placenta. Part II. Clinical application: Diabetes and antidiabetic drugs. Throm Res 1991; 64: 477-85.
5. Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonyl urea, or insulin in patients with type 2 diabetes mellitus: Progression requirement for multiple therapies (UKPDS 49). JAMA 1999; 281: 2005-12.
6. Ohmura C, Tanaka Y, Mitsuhashi N, et al. Efficacy of low dose metformin in Japanese patients with type 2 diabetes mellitus. Current Therapeutic Researchs 1998; 59: 889-95.
7. Reaven GM, Johnson P, Hollenbeck CB, et al. Combined metformin-sulfonylurea treatment of patients with non insulin-dependent diabetes in fair to poor glycemic control. J Clin Endocrinol Metab 1999; 74: 1020-6.
8. Calle Pascual PJ, Vara E, Calle JR, Munguira ME, Maranes JP. Comparison between acarbose, metformin, and insulin treatment in type 2 diabetic patients with secondary failure to sulfonylurea treatment. Diabete Metab (Paris) 1995; 21: 256-60.
9. Hermann LS, Kjellstrom T, Nillson-Ehle P. Effects of metformin and glibenclamide alone and in combination serum lipids and lipoproteins in patients with non insulindependent diabetes mellitus. Diabete Metab 1991; 17: 174-9.
10. Johnson M, Krosnick A, Carson P, McDade AM, Laraway K. A retrospective chart review of uncontrolled use of metformin and add-on therapy in type 2 diabetes. Clinical Therapeutics 1998; 20: 691-8.
11. UK Prospective Diabetes Study (UKPDS) Group/GBR. Effect of intensive blood-glucose control with metformin on complications overweight patients with type 2 diabetes (UKPDS34). Lancet (British Edition) 1998; 352: 854-65.
12. Davidson MB, Peters AL. An overview of metformin in the treatment of type 1 diabetes mellitus. Am J Med 1997; 102: 99-110.
13. Melchior WR, Jaber LA. Metformin: An antihyperglycemic agent for treatment of type II diabetes. Ann Pharmather 1996; 30: 158-64.
14. Laurenti O, Bravi MC, Faldetta MC, De Mattia G. Evaluation of the efficacy of metformin-glibenclamide treatment in overweight non insulin-dependent diabetics. Clin Ther 1992; 140: 259 (abstract).
15. Herman LS, Bitzen PO, Khellstrom T, Lindgarde F, Schertsten B. Comparative efficacy of metformin and glibenclamide in patients with non-insulin dependent diabetes mellitus. Diabete Metab 1991; 17: 201-8.
16. De Fronzo RA. Pharmacologia therapy for type 2 diabetes mellitus. Ann Intern Med 1999; 131: 281-303.